HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
HTL is excited to highlight its participation in IMCAS 2023, a significant event that provided our team with a valuable opportunity to connect with our customers and esteemed partners.
During the event, we had the privilege of sharing insights into our innovative platform and discussing our ambitious future plans. This interaction not only reinforced our relationships but also allowed us to forge new collaborations that will play a role in shaping our company’s journey.
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.
HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.